MedTrace Logo

Bioequivalence of Phenazopyridine HCl in Healthy Volunteers

NCT00743977 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2008-08-29

No results posted yet for this study

Summary

The present study aims at comparing the pharmacokinetics of the original formulation of phenazopyridine and a same generic product.

Conditions

  • Human Volunteers

Interventions

DRUG

Phenazopyridine HCl

100mg tablet in fasting state

Sponsors & Collaborators

  • Universal Enterprises

    lead INDUSTRY

Principal Investigators

  • Waqar H. Kazmi, M.D, M.S.

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2008-11-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00743977 on ClinicalTrials.gov